FULGENZI, FRANCESCA
FULGENZI, FRANCESCA
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study
2022-01-01 Mattioli, M.; Benfaremo, D.; Fulgenzi, F.; Gennarini, S.; Mucci, L.; Giorgino, F.; Frausini, G.; Moroncini, G.; Gnudi, U.
Management of spontaneous soft-tissue hemorrhage secondary to anticoagulant therapy: A cohort study
2018-01-01 Menditto, Vincenzo G.; Fulgenzi, Francesca; Lombardi, Sirio; Dimitriadou, Anna; Mincarelli, Cinzia; Rosati, Marzia; Candelari, Roberto; Pomponio, Giovanni; Salvi, Aldo; Gabrielli, Armando
Predictors of readmission requiring hospitalization after discharge from emergency departments in patients with COVID-19
2021-01-01 Menditto, Vincenzo G; Fulgenzi, Francesca; Bonifazi, Martina; Gnudi, Umberto; Gennarini, Silvia; Mei, Federico; Salvi, Aldo
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
2021-01-01 Mattioli, M.; Benfaremo, D.; Mancini, M.; Mucci, L.; Mainqua, P.; Polenta, A.; Baldini, P. M.; Fulgenzi, F.; Dennetta, D.; Bedetta, S.; Gasperoni, L.; Caraffa, A.; Frausini, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study | 1-gen-2022 | Mattioli, M.; Benfaremo, D.; Fulgenzi, F.; Gennarini, S.; Mucci, L.; Giorgino, F.; Frausini, G.; Moroncini, G.; Gnudi, U. | |
| Management of spontaneous soft-tissue hemorrhage secondary to anticoagulant therapy: A cohort study | 1-gen-2018 | Menditto, Vincenzo G.; Fulgenzi, Francesca; Lombardi, Sirio; Dimitriadou, Anna; Mincarelli, Cinzia; Rosati, Marzia; Candelari, Roberto; Pomponio, Giovanni; Salvi, Aldo; Gabrielli, Armando | |
| Predictors of readmission requiring hospitalization after discharge from emergency departments in patients with COVID-19 | 1-gen-2021 | Menditto, Vincenzo G; Fulgenzi, Francesca; Bonifazi, Martina; Gnudi, Umberto; Gennarini, Silvia; Mei, Federico; Salvi, Aldo | |
| Safety of intermediate dose of low molecular weight heparin in COVID-19 patients | 1-gen-2021 | Mattioli, M.; Benfaremo, D.; Mancini, M.; Mucci, L.; Mainqua, P.; Polenta, A.; Baldini, P. M.; Fulgenzi, F.; Dennetta, D.; Bedetta, S.; Gasperoni, L.; Caraffa, A.; Frausini, G. |